Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab for Rhinovirus-Induced Asthma Exacerbations
NCT01520051Phase 3Unknown
- Sponsor
- University of Amsterdam
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of mepolizumab in allergic asthma, sponsored by University of Amsterdam. Status: unknown.
02
Drugs
mepolizumab
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT01520051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01520051.